Aggrecan Antikörper (N-Term)

Produktnummer ABIN1731433

Produktdetails anti-Aggrecan Antikörper

Target: Aggrecan (ACAN)

Bindungsspezifität: N-Term

Reaktivität: Human, Hamster, Affe

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Aggrecan Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Spezifität: Reacts with Aggrecan from Human, Gorilla, Monkey, Hamster, Pig

Kreuzreaktivität: Ratte (Rattus)

Kreuzreaktivität (Details): Predicted to cross react with Mouse, Rat, Bovine, Horse. BLAST analysis of the peptide immunogen showed no homology with other human proteins, except NCAN (56 % ).

Aufreinigung: Antiserum

Immunogen: Synthetic 18 amino acid peptide from N-terminus of human ACAN / Aggrecan. Percent identity with other species by BLAST analysis: Human, Gorilla, Monkey, Marmoset, Hamster, Pig (100%), Mouse, Rat, Bovine, Panda, Horse (94%), Dog, Elephant (89%), Bat (83%).

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
IHC - P (7 μg/mL)

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: PBS, Sodium azide 0.1 %

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C/-80 °C

Informationen zur Lagerung: Long term: -70°C, Short term: +4°C

Details zu Aggrecan

Target: Aggrecan (ACAN)

Andere Bezeichnung: ACAN / Aggrecan (ACAN Produkte)

Hintergrund: Crucial component of the extracellular matrix of cartilagenous tissue. Mutated form of Aggrecan is involved in skeletal dysplasia and spinal degeneration.

Gen-ID: 176

Pathways: Glycosaminoglycan Metabolic Process, Dicarboxylic Acid Transport